Biofil Chemicals & Pharmaceuticals share news, announcements and annual reports
NSE: BIOFILCHEMBSE: 524396Pharmaceuticals & BiotechnologySmall Cap
Biofil Chemicals & Pharmaceuticals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1994 on BSE, Jun 1996 on NSE
Last close ₹28.68down ₹0.73 (2.48%)BSE ₹29.00
Share price at the NSE close on 30 Oct 2026. Previous close ₹29.41.
30 Oct: open ₹29.00, high ₹29.80, low ₹28.26
52-week range of traded prices to 30 Oct 2026
₹25.60Low, 30 Mar 2026₹46.34High, 3 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹47 Cr3,363rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 96.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.16
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.14
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,71974.4% delivered
Biofil Chemicals & Pharmaceuticals share news and announcements
403 announcements, routine notices left out, newest first. Page 8 of 9.
Aug 2013
7 Aug · Board meeting
To take on record and approve the Un-audited Financial Results of the Company for the quarter ended on June 30, 2013 along with other routine business.
Feb 2013
Nov 2012
2 Nov · Board meeting
To take on record and approve the Un-audited Financial Results of the Company for the quarter ended on September 30, 2012 along with other routine business.
Oct 2012
Sep 2012
4 Sep · Corporate action
Company has fixed the Book Closure from September 24, 2012 to September 28, 2012 for the purpose of Annual General Meeting and Complying of provisions of listing agreement.
Aug 2012
14 Aug · Results
May 2012
29 May · Results
18 May · Board meeting
To consider and approve the Audited Financial Result for the Quarter as well as year ended March 31, 2012 along with other routine business.
Feb 2012
1 Feb · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on December 31, 2011 along with other routine business.
Nov 2011
3 Nov · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on September 30, 2011 alongwith other routine business.
Aug 2011
22 Aug · Corporate action
Company has fixed the Book Closure from September 24, 2011 to September 29, 2011 for the purpose of Annual General Meeting and Complying of provisions of listing agreement.
Jul 2011
25 Jul · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on June 30, 2011 alongwith other routine business.21 Jul · Change in Registrar & Share Transfer Agent
Registered office of the Company's Registrar and share transfer agent M/s Ankit Consultancy Private Limited have been shifted from 4-A, Alankar Point , Geeta Bhawan Chouraha, A.B.Road, Indore- 452001 (M.P.) to Ankit Consultancy Private Limited, Plot no. 60, Electronic Complex, Pardeshipura, Indore- 452010 (M.P.) Email ID: ankit_4321@yahoo.com with effect from July 01, 2011.
May 2011
24 May · Board meeting
To consider and approve the Audited Financial Result for the Quarter as well as year ended March 31, 2011 along with other routine business.
Apr 2011
Mar 2011
29 Mar · Board meeting
Members of the Company have accorded their permission on March 23, 2011 to re-issue of 57,12,500 forfeited equity shares at the price of Rs. 7/- each. For this purpose a meeting of Board of Directors of the company is scheduled to be held on March 31, 2011 for allotment of the 5712500 forfeited equity shares.23 Mar · Meeting
An Extra-ordinary General Meeting held on March 23, 2011 the members of the company have passed special resolution for re-issuance of forfeited 5712500 equity shares subject to confirmation of appropriate authority.
Feb 2011
21 Feb · Board meeting
At the Board meeting held on February 21, 2011 the Board has passed resolution for re-issuance of forfeited 5712500 equity shares subject to confirmation of shareholders in ensuing Extra- Ordinary general Meeting of the company which is scheduled to be held on March 23, 2011.21 Feb · Board meeting
To consider the matter relating to re-issuance of the forfeited 5712500 equity shares of Rs. 10 each.9 Feb · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on December 31, 2010.
Nov 2010
12 Nov · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on September 30, 2010.
Oct 2010
5 Oct · Meeting
Annual General Meeting of the Company was held on September 28, 2010. The resolutions as set out in the notice dated July 31, 2010 for following transactions were passed unanimously: (1) Adoption of the Audited Balance Sheet as at March 31, 2010 and Profit and Loss Account for the year ended March 31, 2010 and the Reports of the Directors and Auditors thereon. (2). Re-appointment of Mr. Ramesh Chimanlal Shah who retire by rotation. (3). Re-appointment M/s. S.N. Gadiya & Company, Chartered Accountants, Indore as Statutory Auditors of the Company from the conclusion of this Annual General Meeting to the conclusion of the next Annual General Meeting.
Aug 2010
10 Aug · Board meeting
To take on record the Un-audited Financial Results of the Company for the quarter ended on June 30, 2010.
Jan 2010
13 Jan · Board meeting
Meeting on 30 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
16 Oct · Board meeting
Meeting on 31 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”5 Oct · Meeting
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange rearding the outcome of Annual General meeting held on September 30, 2009. The resolutions as set out in the notice dated August 25, 2009 for following transactions were passed unanimously: (1) Adoption of the Audited Balance Sheet as at March 31, 2009 and Profit and Loss Account for the year ended March 31, 2009 and the Reports of the Directors and Auditors thereon. (2). Re-appointment of Mr. Navneet Bagree who retire by rotation. (3). Appointment M/s. S.N. Gadiya & Company, Chartered Accountants, Mumbai as Statutory Auditors of the Company from the conclusion of this Annual General Meeting to the conclusion of the next Annual General Meeting.
Sep 2009
1 Sep · Corporate action
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Company has fixed the Book Closure from September 25, 2009 to September 30, 2009 for the purpose of Annual General Meeting and Complying of provisions of listing agreement.
Jun 2009
11 Jun · Board meeting
To consider and approve the Audited Financial Result for Quarter as well as the year ended March 31,2009.
Apr 2009
20 Apr · Results
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Board has decided to submit/ publish the Audited Financial Results for the year ended on March 31, 2009 with in the prescribed time limit stipulated in the listing agreement.
Feb 2009
24 Feb · Disclosure
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that promoters of the company have confirmed that none of their shareholding in the company are pledged as on 28.01.2009. Further the company has submitted to the Exchange a copy of disclosure pursuant to regulation 8A of SEBI (SAST) Amendments Regulations, 2009. A copy of the shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
16 Jan · Board meeting
Meeting on 31 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
14 Oct · Board meeting
Meeting on 31 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Aug 2008
14 Aug · Corporate action
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the company has announced Book Closure from September 23, 2008 to September 30, 2008 for the purpose of Annual General Meeting and Complying of provisions of listing agreement.
Jul 2008
30 Jul · Disclosure
Ramesh Shah alongwith Smitesh Shah, Ketan Shah and Sandeep Shah proposes to acquire 1284200 equity shares aggregating to 12.16% of the shares/voting rights of Biofil Chemicals & Pharmaceuticals Limited from Systematix Corporate Services Limited, Systematix Leasing & Investments Ltd. (Now Gems Equities & Securities Pvt Ltd). and Systematix Mercantile Ltd. The mode of proposed acquisition is by way of Inter-se Promoter Transfer & the date of proposed acquisition is August 05, 2008. The proposed acquisition price per share is Proposed to be an off market transaction (Rs. 0.36 per share). The shareholding of Ramesh Shah, Smitesh Shah, Ketan Shah and Sandeep Shah after the proposed acquisition would be 1599300 shares aggregating to 15.14% of the shares/voting rights of Biofil Chemicals & Pharmaceuticals Limited. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Jul · Board meeting
Meeting on 31 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Apr 2008
24 Apr · Results
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange: "Board has decided to submit / publish the Audited Financial Results for the year ended on 31st March, 2008 with in the prescribed time limit stipulated in the listing agreement and the same will be submitted to you with in the prescribed time limit."
Feb 2008
1 Feb · Results
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that Board of the Directors of the Company as its meeting held January 31, 2008 has announced the result for postal ballot through which the shareholders of the Company have passed an ordinary resolution to authorize the Board of Directors to sell the unit situated at the Sanwer Road, Indore in terms of section 293 (1) (a) read with section 192A of the Companies Act, 1956". Further the Company has submitted a copy of scrutinizer report. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
18 Jan · Meeting
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that pursuant to section 293(1)(a) and 192A of the companies Act, 1956 read with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001 and any amendments thereto, the following resolution is to be approved by the shareholders of the Company by way of an ordinary resolution and passed by Postal Ballot: Ordinary resolution under section 293(1)(a) of the Companies Act, 1956 in relation to authorization to board to sell the unit situated at Sanwer Road, Indore. The Company has appointed Mr. L.N. Joshi Company Secretaries, as Scrutinizer to scrutinize the Postal Ballots in a fair and transparent manner. The duly completed postal ballot forms should reach the scrutinizer before the close of working hours, on or before, January 28, 2008. The result of postal ballot will be announced by the Chairman on January 31, 2008. A copy of the Notice of Postal Ballot shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Jan · Board meeting
To take on record and aprove the Un-audited Financial Results of the Company for the quarter ended December 31, 2007. Further The results of the postal ballot will be declared by the Chairman and Managing Director of the Company on January 31, 2008.
Dec 2007
6 Dec · Board meeting
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that the Board of Directors of the Company in their meeting held on December 05, 2007 have decided to sell the unit situated at the Sanwer Road, Indore subject to approval of the members by way of postal ballot and for this purpose Mr. L.N. Joshi Company Secretary in practice be and is hereby appointed as scrutinizer.
Nov 2007
29 Nov · Board meeting
To transact the following business: (1) To consider the matter of sale, lease or otherwise dispose of the Manufacturing unit situated at Sanwer Road, Indore, M.P in terms of Section 293 (1) (a) read with 192A of the Companies Act.1956. (2) To appoint scrutinizer to conduct the postal ballot process in fair and transparent manner in terms of section 192A of the Companies Act, 1956.
Oct 2007
19 Oct · Board meeting
Meeting on 31 Oct 2007: “Unaudited Financial Results for the Qtr ended Sept 30, 2007”
Sep 2007
12 Sep · Corporate action
Biofil Chemicals & Pharmaceuticals Ltd. has informed the Exchange that they have announced Book Closure from September 24, 2007 to September 29, 2007 for the purpose of Annual General Meeting and Complying of provisions of listing agreement.